ATP released via pannexin-1 hemichannels mediates bladder overactivity triggered by urothelial P2Y6 receptors.

Biochem Pharmacol

Laboratório de Farmacologia e Neurobiologia/UMIB, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), Porto, Portugal. Electronic address:

Published: January 2014

In contrast to the well-known signaling role of urothelial ATP to control bladder function, the hypothesis that uracil nucleotides (UTP and/or UDP) also exert autocrine/paracrine actions only recently gained experimental support. Urothelial cells express UDP-sensitive P2Y6 receptors, yet their role in the control of bladder activity has been mostly neglected. This study was designed to investigate the ability of PSB0474, a stable UDP analogue which exhibits selectivity for P2Y6 receptors, to modulate urodynamic responses in the anaesthetized rat in vivo. Instillation of PSB0474 into the bladder increased the voiding frequency (VF) without affecting the amplitude (A) and the duration (Δt) of bladder contractions. PSB0474-induced bladder overactivity was prevented by the selective P2Y6 antagonist, MRS2578. The increase in the VF produced by PSB0474 was also blocked by inhibitors of pannexin-1 hemichannels, (10)Panx or carbenoxolone, when these drugs were applied inside the bladder lumen but not when they were administered intravenously. Reduction of hemichannels pore permeability with H1152 also prevented PSB0474-induced bladder overactivity, but the exocytosis inhibitor, Exo-1, was inactive. PSB0474 increased by 3-fold the urinary ATP content. Implication of hemichannels permeability on PSB0474-induced ATP release was demonstrated by real-time fluorescence video-microscopy measuring the uptake of propidium iodide by intact urothelial cells in the absence and in the presence of MRS2578 or carbenoxolone. Confocal microscopy studies confirmed the co-localization of pannexin-1 and P2Y6 receptors in the rat urothelium. Data indicate that activation of P2Y6 receptors causes bladder overactivity in the anaesthetized rat indirectly by releasing ATP from the urothelium via pannexin-1 hemichannels.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2013.11.007DOI Listing

Publication Analysis

Top Keywords

p2y6 receptors
20
bladder overactivity
16
pannexin-1 hemichannels
12
bladder
9
control bladder
8
urothelial cells
8
anaesthetized rat
8
psb0474-induced bladder
8
p2y6
6
atp
5

Similar Publications

P2RY6 deletion promotes UVB-induced skin carcinogenesis by activating the PI3K/AKT signal pathway.

Cancer Sci

January 2025

Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.

Our previous research has demonstrated that P2RY6 functions as an oncogene in DMBA/TPA-induced two-stage chemical skin carcinogenesis in mice. However, considering that human skin cancer is predominantly attributed to UV radiation from sunlight, additional investigations are needed to elucidate the role of P2RY6 in UVB-induced skin carcinogenesis. Surprisingly, we found that P2ry6-deficient mice exhibited marked promotion to UVB-induced skin papilloma formation compared with wild-type mice, suggesting its tumor-suppressive role in UVB-induced skin cancer.

View Article and Find Full Text PDF

Modification of Neural Circuit Functions by Microglial P2Y6 Receptors in Health and Neurodegeneration.

Mol Neurobiol

October 2024

International Joint Research Centre on Purinergic Signaling, School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Article Synopsis
  • - The central nervous system (CNS) relies on neural circuits made up of neurons and glial cells, with microglia acting as the immune cells that manage synapse elimination and refinement through P2Y6 receptors (P2Y6Rs).
  • - P2Y6Rs are crucial in both neurodegenerative diseases like Alzheimer's and Parkinson's, as well as in neuroinflammation caused by various factors, by regulating microglial cytokines such as IL-1β and TNF-α.
  • - The review explores how antagonists targeting P2Y6Rs might relieve inflammation-related neurological issues but cautions that they could also disrupt the delicate balance of synaptic communication in the brain.
View Article and Find Full Text PDF

Discovery of a potent, Highly selective, and In vivo anti-inflammatory Efficacious, P2YR antagonist with a novel quinoline-pyrazole scaffold.

Eur J Med Chem

December 2024

Henan Provincial Key Laboratory of Pediatric Hematology, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou, 450018, China. Electronic address:

The P2Y receptor (P2YR), as a crucial member of the purine family, is a potential therapeutic target for the treatment of intestinal inflammation, tracheal inflammation and diabetes. We first discovered the hit compound (5a, IC = 168.5 nM against P2YR) through our in-house library screening.

View Article and Find Full Text PDF

The P2Y6 Receptor as a Potential Keystone in Essential Hypertension.

Function (Oxf)

November 2024

Departamento de Bioquímica y Biología Molecular y Fisiología e Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid y Consejo Superior de Investigaciones Científicas (CSIC), Valladolid, 47003, Spain.

Essential hypertension (HT) is a highly prevalent cardiovascular disease of unclear physiopathology. Pharmacological studies suggest that purinergic P2Y6 receptors (P2ry6) play important roles in cardiovascular function and may contribute to angiotensin II (AgtII) pathophysiological effects. Here, we tested the hypothesis that functional coupling between P2ry6 and AgtII receptors mediates altered vascular reactivity in HT.

View Article and Find Full Text PDF

Purinergic signaling in liver disease: calcium signaling and induction of inflammation.

Purinergic Signal

September 2024

Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, USA.

Article Synopsis
  • * Abnormal calcium signaling caused by specific purinergic receptors (like P2X7 and certain P2Y receptors) can disrupt normal liver cell functions and activate other liver cells, leading to immune responses associated with liver damage and fibrosis.
  • * Targeting purinergic receptors with pharmacological interventions may offer new treatment options for liver conditions by modulating calcium signaling and reducing complications like hepatic steatosis and fibrosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!